Intensity modulated radiotherapy in gynecologic cancers: Hope, hype or hyperbole?

Gynecologic Oncology

Volumn 130, Issue 1, 2013, Pages 229-236

  Wagner, Aaron ^a   Jhingran, Anuja ^b   Gaffney, David ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cervical; Endometrial; Gynecologic; IMRT

Indexed keywords

DOSIMETRY; ENDOMETRIUM CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MOTION; OUTCOMES RESEARCH; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TUMOR REGRESSION; UTERINE CERVIX CANCER;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; RADIOTHERAPY, INTENSITY-MODULATED; UTERINE CERVICAL NEOPLASMS;

EID: 84879079158     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.04.052     Document Type: Review

References (63)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 1 Jan. 2013 11 30
2. T. Högberg, B. Glimelius, P. Nygren SBU-group Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in ovarian cancer Acta Oncol 40 2-3 2001 340 360
3. C.W. Whitney, W. Sause, B.N. Bundy, J.H. Malfetano, E.V. Hannigan, and W.C. Fowler Jr Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348
4. M. Morris, P.J. Eifel, J. Lu, P.W. Grigsby, C. Levenback, and R.E. Stevens Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
5. P.J. Eifel, K. Winter, M. Morris, C. Levenback, P.W. Grigsby, and J. Cooper Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01 J Clin Oncol 22 2004 872 880
6. R. Pearcey, M. Brundage, P. Drouin, J. Jeffrey, D. Johnston, and H. Lukka Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix J Clin Oncol 20 2002 966 972
7. P.G. Rose, S. Ali, E. Watkins, J.T. Thigpen, G. Deppe, and D.L. Clarke-Pearson Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study J Clin Oncol 25 2007 2804 2810
8. H.M. Keys, B.N. Bundy, F.B. Stehman, L.I. Muderspach, W.E. Chafe, and C.L. Suggs III Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161
9. F.B. Stehman, S. Ali, H.M. Keys, L.I. Muderspach, W.E. Chafe, and D.G. Gallup Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial Am J Obstet Gynecol 197 2007 503.e1 503.e6
10. P.G. Rose, B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, and M.A. Maiman Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
11. M. Elshaikh, M. Ljungman, R. Ten Haken, and A.S. Lichter Advances in radiation oncology Annu Rev Med 57 2006 19 31
12. L.L. Gunderson, and J.E. Tepper Chapter 15, Conformal therapy and intensity-modulated radiation therapy: treatment planning, treatment delivery, and clinical results Clinical radiation oncology 3rd ed. 2012 Elselvier Saunders Philadelphia 287 315
13. L.K. Mell, A.K. Mehrotra, and A.J. Mundt Intensity-modulated radiation therapy use in the U.S., 2004 Cancer 104 6 2005 Sep 15 1296 1303
14. J.C. Roeske, A. Lujan, J. Rotmensch, S.E. Waggoner, D. Yamada, and A.J. Mundt Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies Int J Radiat Oncol Biol Phys 48 5 2000 Dec 1 1613 1621
15. D.E. Heron, K. Gerszten, R.N. Selvaraj, G.C. King, D. Sonnik, and H. Gallion Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms Gynecol Oncol 91 1 2003 Oct 39 45
16. L. Portelance, K.S. Chao, P.W. Grigsby, H. Bennet, and D. Low Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation Int J Radiat Oncol Biol Phys 51 1 2001 Sep 1 261 266
17. S. Iǧdem, T. Ercan, G. Alço, F. Zengin, R. Ozgüleş, and G. Geceer Dosimetric comparison of intensity modulated pelvic radiotherapy with 3D conformal radiotherapy in patients with gynecologic malignancies Eur J Gynaecol Oncol 30 5 2009 547 551
18. D. Georg, P. Georg, M. Hillbrand, R. Pötter, and U. Mock Assessment of improved organ at risk sparing for advanced cervix carcinoma utilizing precision radiotherapy techniques Strahlenther Onkol 184 11 2008 Nov 586 591
19. A.E. Lujan, A.J. Mundt, S.D. Yamada, J. Rotmensch, and J.C. Roeske Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy Int J Radiat Oncol Biol Phys 57 2 2003 Oct 1 516 521
20. R.S. Ahmed, R.Y. Kim, J. Duan, S. Meleth, J.F. De Los Santos, and J.B. Fiveash IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk Int J Radiat Oncol Biol Phys 60 2 Oct. 1 2004 505 512
21. L.K. Mell, H. Tiryaki, K.H. Ahn, A.J. Mundt, J.C. Roeske, and B. Aydogan Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer Int J Radiat Oncol Biol Phys 71 5 Aug. 1 2008 1504 1510
22. B. Yang, L. Zhu, H. Cheng, Q. Li, Y. Zhang, and Y. Zhao Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis Radiat Oncol 7 Nov. 23 2012 197
23. A.J. Mundt, A.E. Lujan, J. Rotmensch, S.E. Waggoner, S.D. Yamada, and G. Fleming Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies Int J Radiat Oncol Biol Phys 52 5 Apr. 1 2002 1330 1337
24. A.J. Mundt, L.K. Mell, and J.C. Roeske Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy Int J Radiat Oncol Biol Phys 56 5 Aug. 1 2003 1354 1360
25. X.L. Du, J. Tao, X.G. Sheng, C.H. Lu, H. Yu, and C. Wang Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy Gynecol Oncol 125 1 Apr. 2012 151 157
26. M.F. Chen, C.J. Tseng, C.C. Tseng, C.Y. Yu, C.T. Wu, and W.C. Chen Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients Cancer J 14 3 May-Jun. 2008 200 206
27. K.K. Shih, S.A. Milgrom, N.R. Abu-Rustum, M.A. Kollmeier, G.J. Gardner, and W.P. Tew Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer Gynecol Oncol 128 3 Mar. 2013 535 539
28. M.R. Folkert, K.K. Shih, N.R. Abu-Rustum, E. Jewell, M.A. Kollmeier, and V. Makker Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate-and high-risk cervical cancer Gynecol Oncol 128 2 Feb. 2013 288 293
29. S. Beriwal, G.N. Gan, D.E. Heron, R.N. Selvaraj, H. Kim, and R. Lalonde Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer Int J Radiat Oncol Biol Phys 68 1 May 1 2007 166 171
30. C.C. Chen, J.C. Lin, J.S. Jan, S.C. Ho, and L. Wang Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer Gynecol Oncol 122 1 Jul. 2011 9 13
31. S. Beriwal, S.K. Jain, D.E. Heron, H. Kim, K. Gerszten, and R.P. Edwards Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy Gynecol Oncol 102 2 Aug. 2006 195 199
32. M.D. Hasselle, B.S. Rose, J.D. Kochanski, S.K. Nath, R. Bafana, and C.M. Yashar Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix Int J Radiat Oncol Biol Phys 80 5 Aug. 1 2011 1436 1445
33. E.A. Kidd, B.A. Siegel, F. Dehdashti, J.S. Rader, S. Mutic, and D.G. Mutch Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer Int J Radiat Oncol Biol Phys 77 4 Jul. 15 2010 1085 1091
34. W.A. Peters 3rd, P.Y. Liu, R.J. Barrett 2nd, R.J. Stock, B.J. Monk, and J.S. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 8 Apr. 2000 1606 1613
35. A.H. Klopp, J. Moughan, L. Portelance, B.E. Miller, M.R. Salehpour, and D. D'Souza Hematologic Toxicity on RTOG 0418: a phase II study of post-operative IMRT for gynecologic cancer Int J Radiat Oncol Biol Phys 78 3 Nov. 2010 S121
36. B.S. Rose, Y. Liang, S.K. Lau, L.G. Jensen, C.M. Yashar, and C.K. Hoh Correlation between radiation dose to 1̧F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy Int J Radiat Oncol Biol Phys 83 4 Jul. 15 2012 1185 1191
37. Y. Liang, M. Bydder, C.M. Yashar, B.S. Rose, M. Cornell, and C.K. Hoh Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies Int J Radiat Oncol Biol Phys 85 2 Feb. 1 2013 406 414
38. K. Greven, K. Winter, K. Underhill, J. Fontenesci, J. Cooper, and T. Burke Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer Gynecol Oncol 103 1 Oct. 2006 155 159
39. L. Portelance, J. Moughan, A. Jhingran, B.E. Miller, M.R. Salehpour, and D. D'Souza A phase II multi-institutional study of postoperative pelvic intensity modulated radiation therapy (IMRT) with weekly cisplatin in patients with cervical carcinoma: two year efficacy results of RTOG 0418 Int J Radiat Oncol Biol Phys 81 2 Oct. 1 2011 S3
40. A. Jhingran, K. Winter, L. Portelance, B.E. Miller, M.R. Salehpour, and R. Gaur Efficacy and safety of IMRT after surgery in patients with endometrial cancer: RTOG 0418 phase II study Int J Radiat Oncol Biol Phys 81 2 Oct. 1 2011 S3
41. E.A. Kidd, B.A. Siegel, F. Dehdashti, J.S. Rader, D.G. Mutch, and M.A. Powell Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis J Clin Oncol 28 12 Apr. 20 2010 2108 2113
42. B.D. Kavanagh, C.C. Pan, L.A. Dawson, S.K. Das, X.A. Li, and R.K. Ten Haken Radiation dose-volume effects in the stomach and small bowel Int J Radiat Oncol Biol Phys 76 3 Suppl. Mar. 1 2010 S101 S107
43. M.A. Varia, B.N. Bundy, G. Deppe, R. Mannel, H.E. Averette, and P.G. Rose Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study Int J Radiat Oncol Biol Phys 42 5 Dec. 1 1998 1015 1023
44. M. Rotman, T.F. Pajak, K. Choi, M. Clery, V. Marcial, and P.W. Grigsby Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20 JAMA 274 5 Aug. 2 1995 387 393
45. K. Gerszten, K. Colonello, D.E. Heron, R.J. Lalonde, I.D. Fitian, and J.T. Comerci Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix Gynecol Oncol 102 2 Aug. 2006 182 188
46. P.D. Poorvu, C.A. Sadow, K. Townamchai, A.L. Damato, and A.N. Viswanathan Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes Int J Radiat Oncol Biol Phys Nov. 20 2012 10.1016/j.ijrobp.2012.10. 004 [pii: S0360-3016(12)03654-1]
47. S.M. Shirvani, A.H. Klopp, A. Likhacheva, A. Jhingran, P.T. Soliman, and K.H. Lu Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer Practical Radiation Oncology 3 1 2013 e21 e28
48. International Commission on Radiation Units and Measurements ICRU Report 50: prescribing, recording, and reporting photon beam therapy 1993 Bethesda MD
49. A. Jhingran, K. Winter, L. Portelance, B. Miller, M. Salehpour, and R. Gaur A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418 Int J Radiat Oncol Biol Phys 84 1 Sep. 1 2012 e23 e28
50. W. Small Jr., L.K. Mell, P. Anderson, C. Creutzberg, J. De Los Santos, and D. Gaffney Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer Int J Radiat Oncol Biol Phys 71 2 2008 Jun 1 428 434
51. W.R. Lee, W.M. McCollough, W.M. Mendenhall, R.B. Marcus Jr., J.T. Parsons, and R.R. Million Elective inguinal lymph node irradiation for pelvic carcinomas. The University of Florida experience Cancer 72 6 1993 Sep 15 2058 2065
52. C.H. Kim, A.C. Olson, H. Kim, and S. Beriwal Contouring inguinal and femoral nodes; how much margin is needed around the vessels? Practical Radiation Oncology 2 2012 274 278
53. K. Lim, W. Small Jr., L. Portelance, C. Creutzberg, I.M. Jürgenliemk-Schulz, and A. Mundt Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer Int J Radiat Oncol Biol Phys 79 2 2011 Feb 1 348 355
54. E.E. Harris, K. Latifi, C. Rusthoven, K. Javedan, and K. Forster Assessment of organ motion in postoperative endometrial and cervical cancer patients treated with intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 81 4 Nov. 15 2011 e645 e650
55. N.H. Haripotepornkul, S.K. Nath, D. Scanderbeg, C. Saenz, and C.M. Yashar Evaluation of intra-and inter-fraction movement of the cervix during intensity modulated radiation therapy Radiother Oncol 98 3 Mar. 2011 347 351
56. A. Jhingran, M. Salehpour, M. Sam, L. Levy, and P.J. Eifel Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy Int J Radiat Oncol Biol Phys 82 1 Jan. 1 2012 256 262
57. A. Ahamad, W. D'Souza, M. Salehpour, R. Iyer, S.L. Tucker, and A. Jhingran Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size Int J Radiat Oncol Biol Phys 62 4 Jul. 15 2005 1117 1124
58. C.M. Lee, D.C. Shrieve, and D.K. Gaffney Rapid involution and mobility of carcinoma of the cervix Int J Radiat Oncol Biol Phys 58 2 Feb. 1 2004 625 630
59. L. van de Bunt, U.A. van der Heide, M. Ketelaars, G.A. de Kort, and I.M. Jürgenliemk Schulz Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: the impact of tumor regression Int J Radiat Oncol Biol Phys 64 1 Jan. 1 2006 189 196
60. B.M. Beadle, A. Jhingran, M. Salehpour, M. Sam, R.B. Iyer, and P.J. Eifel Cervix regression and motion during the course of external beam chemoradiation for cervical cancer Int J Radiat Oncol Biol Phys 73 1 Jan. 1 2009 235 241
61. A. Konski, D. Watkins-Bruner, S. Feigenberg, A. Hanlon, S. Kulkarni, and J.R. Beck Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer Int J Radiat Oncol Biol Phys 66 2 Oct. 1 2006 408 415
62. E.J. Hall, and C.S. Wuu Radiation-induced second cancers: the impact of 3D-CRT and IMRT Int J Radiat Oncol Biol Phys 56 1 May. 1 2003 83 88
63. S.F. Kry, M. Salehpour, D.S. Followill, M. Stovall, D.A. Kuban, and R.A. White The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 62 4 Jul. 15 2005 1195 1203